2m 2m 2m 2m 2m 2m 2m
EDGEWISE THERAP (EWTX)
NASDAQ
$38.39-$0.05 (-0.12%)
Price as of Aug 03, 2026 5:53 AM EDT- $4.1BMarket Cap
- 168.55%1-Year Change
- BiotechnologyIndustry
EDGEWISE THERAP (EWTX)
$38.39-$0.05 (-0.12%)
EWTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $38.43 | ||
Change | -$2.69 (-6.54%) | ||
Open | $41.11 | ||
High | $41.11 | ||
Low | $38.21 | ||
Previous Close | $41.12 | ||
Volume | 1,150,197 | ||
30-Day Average Volume | 1,011,687 | ||
1-Week Change | -5.90% | ||
1-Month Change | -5.41% | ||
1-Year Change | 168.55% | ||
3-Year Change | 427.16% | ||
5-Year Change | 119.47% | ||
Fundamentals | |||
Shares Outstanding | 107.6M | ||
Total Assets | $518.5M | ||
Market Cap | $4.1B | ||
Enterprise Value | $4.1B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$49.0M | ||
Free Cash Flow | -$42.8M | ||
EBIT | -$49.0M | ||
EBITDA | -$48.5M | ||
Net Working Capital | $487.2M | ||
EPS | -$0.46 | ||
Enterprise Value/EBITDA | -85 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 8 | ||
P/E | -84 | ||
PEG | -29 | ||
Price/Free Cash Flow | -97 | ||
Price/Operating Cash Flow | -97 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue